ClinicalTrials.Veeva

Menu

Use of Involvement Matrix in Cerebral Palsy Into Spain and Brazil (InMatrix-CP)

U

University of Castilla-La Mancha

Status

Unknown

Conditions

Participation
Public and Patient Involvement
Family Research
Patient Participation

Treatments

Other: co-design in the intervention manual elaboration to increase the participation in the community

Study type

Observational

Funder types

Other

Identifiers

NCT05214352
Rpalomo02

Details and patient eligibility

About

Application of Involvement Matrix in young people with Cerebral Palsy (GMFCS levels IV and V) from 12 to 17 years old with the purpose of improving the participation of this group in community leisure activities

Full description

The "Involvement Matrix" is a tool, which was built with organizations of patients, patients, parents, educators, doctors, and researchers, and supports the conversation and discussion about roles and expectations, aiming at authentic and sustainable alliances in research. It includes five participation roles: Listener, Co-thinker, Advisor, Partner and Decision-maker in three main phases of the research project: Preparation, Execution, and Implementation. The Involvement Matrix aims to be a guide for the project leader or researcher to dialogue with patients (public). Using the Matrix, agreements are made about the roles that the patient wishes to acquire and how they are involved in each phase. In this way, the empty cells in the Matrix are filled with specific activities.

Using the Involvement Matrix before and during the different phases of a project has the potential to help researchers and patients reach clear agreements about research and their participation. The tool can be used prospectively, to discuss the possible roles of patients in the different phases of the projects, and retrospectively to discuss whether the roles have been satisfactorily performed. It is known that some studies with PPI had children and young people with the most severe disabilities as active participants and with non-verbal communication, thus, the most effective ways to collaborate with this group should be developed and enhanced to encourage their involvement in research. Although periodicals on the PPI are increasing rapidly, a solid evidence base of the impact of the PPI on research is still lacking, as many publications relate to the PPI process in general and without addressing the real impact of the PPI on the research.

In this sense, the goal of this project is "to develop (co-production) an intervention program for young people with Cerebral Palsy (GMFCS levels IV and V) from 12 to 17 years old with the purpose of improving the participation of this group in community leisure activities and assess the viability of public involvement in the research project through the use of the Involvement Matrix ".

Enrollment

24 estimated patients

Sex

All

Ages

12 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • young people diagnosed with Cerebral Palsy (CP) from 12 to 17 years old, levels IV-V within the Gross Motor Function Classification System (GMFCS)
  • preserved cognitive status
  • families willing to cooperate with the research, as well as the physiotherapists and occupational therapists that accept to participate in the study.

Exclusion criteria

  • young people with an inadequate cognitive level (CI <70) to answer questions and collaborate, with other problems or diseases not associated with CP
  • non-cooperative families, and physiotherapists and occupational therapists who do not agree to sign the informed consent form for inclusion in the study

Trial design

24 participants in 1 patient group

young population with cerebral palsy-Families-Therapist and researchers
Description:
The principal group is designed by all people who composed the research and who will work together in the intervention manual elaboration on the participation in the community.
Treatment:
Other: co-design in the intervention manual elaboration to increase the participation in the community

Trial contacts and locations

1

Loading...

Central trial contact

Rocío Palomo-Carrión, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems